Most peels sold into practices today are chosen by acid and by concentration. You pick a depth, you accept a recovery window, and you book the follow-up around it. That trade-off is so familiar it stops looking like a trade-off.
Fourth-generation peeling is the category label for a peel built to work without that step. The label is worth unpacking, because a number on its own tells you nothing.
The number is a category label, not a certified tier
No standards body issues peel generations. There is no registry, no audit, no committee that moved the field from third to fourth. Anyone who tells you otherwise is selling the number rather than the mechanism.
What the label points at is a real distinction. A traditional chemical peel produces renewal through controlled inflammation: a measured injury is provoked, and the skin repairs itself on the way back. Resurfacing devices reach a similar endpoint by a different route — thermal or mechanical rather than chemical. Both approaches work, and both carry the same structural cost. The visible recovery is part of the treatment, not an unwanted side effect of it.
A fourth-generation peeling solution is defined by taking that step out of the sequence. LHALA Peel is built to renew the skin while adsorbing and removing inflammation-inducing substances, instead of depending on inflammation to generate the result. That single change is where the category claim lives. Everything else follows from it.
What LHA contributes
LHA is lipo-hydroxy acid — capryloyl salicylic acid, a salicylic acid derivative carrying an eight-carbon fatty chain. Two properties of that molecule matter in a peel.
It is larger than salicylic acid, so it penetrates more gradually rather than arriving all at once. And it is more lipophilic, which gives it affinity for the lipid environment of the follicle instead of only the surface of the stratum corneum. A slower, more even distribution is a different profile from a fast, aggressive one — not a stronger version of it.
In LHALA Peel, LHA sits alongside INCUBE 504 and H2sol, in a lipid base. INCUBE is the component that applies MOF principles — Metal-Organic Frameworks, the chemistry recognized by the 2025 Nobel Prize in Chemistry — to adsorb and remove inflammation-inducing substances during the peel itself. We wrote about that chemistry separately, because it deserves more room than a paragraph.
What it changes in the room
The mechanism argument only matters if it shows up in the schedule. Three places where it does:
Booking. A protocol with no visible recovery window is not constrained by the client’s calendar. The appointment before a wedding, a shoot, or a Monday morning stops being a conversation about timing.
Completion of the series. Peel courses are usually sold in threes and fours. The drop-off rarely happens because the result disappointed — it happens after the first recovery period costs someone a weekend. Removing that cost removes the most common reason a series ends early.
Sequencing with what you already run. A peel that does not leave the barrier compromised is easier to place next to microneedling, injectables or device work in a treatment plan, rather than fencing it off in its own recovery window.
What is on file, and what is not
The reason to state this plainly is that the alternative is worse. A category claim that cannot be separated from its evidence is a claim you cannot defend to a client.
Testing on file. LHALA Peel Basic and LHALA Peel Ultra each completed a skin irritation test with 30 volunteers per format, returning a non-irritant result. That is irritation testing. It is not efficacy testing, and the results are specific to those two formats.
Skin type coverage. Suitability across Fitzpatrick types I to VI, and the absence of rebound, are the brand’s positioning statements. Product-specific evidence supporting them has not yet been supplied, so neither should be presented as tested or proven.
Intellectual property. INCUBE is covered by Korean patents granted to LabInCube (KR102768791B1) and to LabInCube with Sookmyung Women’s University (KR102854328B1). H2sol is a pending Korean application (KR 10-2024-0109462) with no grant identified. These are third-party rights: the technology is not patented by LHALALA or by H2MEDI.
How to evaluate it against what you already offer
Four questions worth asking of any peel presented as a new category, this one included:
- What is the stated mechanism, in one sentence, without adjectives?
- Which testing exists, on which specific format, and what does that testing actually measure?
- Where does it sit in a protocol — prep, active step, or finish — and what does it require on either side?
- What is the honest recovery profile, described by someone willing to name its limits?
LHALA Peel is intended for professional, in-office use, external use only. If the mechanism above is relevant to protocols you already run, the technology page covers the formulation in more depth, and the U.S. team can walk through protocol placement and account terms.